Immunovant has stopped development of IMVT-1402 in cutaneous lupus erythematosus after failing a midphase test, closing off ...

GSK has been operating a strategy of “balancing the West and the East” since the British pharma’s eyes were opened to the potential of licensing drugs from China a few years ago, according to an ...

Roche has reported a phase 3 win for sefaxersen in kidney disease, teeing up talks with regulators about the path to approval for the Ionis Pharmaceuticals-partnered, would-be blockbuster drug ...

Medtech startup Anaconda Biomed has hauled in $53 million to help finish off work on a pivotal trial for its endovascular project. | Medtech startup Anaconda Biomed has hauled in $53 million to help ...